Immunocore Insider Trades
NASDAQ: IMCRHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 10 · $5.63M
- Shares bought / sold
- 0 / 144.09K
- Net activity
- Net selling $5.6 million
Immunocore insider activity
Over the last 12 months, Immunocore insiders reported 20 transactions on SEC Form 4: 0 open-market purchases and 10 sales. Insiders bought $0 and sold $5.6 million worth of stock, for net insider selling of $5.6 million. The largest seller was Berman David M, with $5.2 million in reported sales.
The most recent filing shows GOLL JOHN (SVP, FINANCE & CAO) selling 698 shares at $32.35 on Feb 18, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put IMCR's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
IMCR insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Feb 18, 2026 | Jallal BahijaCHIEF EXECUTIVE OFFICER | Sale | 11,474 | $371.18K | Form 4 |
| Feb 18, 2026 | Berman David MHEAD OF R&D | Sale | 5,965 | $192.97K | Form 4 |
| Feb 18, 2026 | St Leger Tina AmberCHIEF HR OFFICER | Sale | 1,000 | $32.35K | Form 4 |
| Feb 18, 2026 | GOLL JOHNSVP, FINANCE & CAO | Sale | 698 | $22.58K | Form 4 |
| Feb 17, 2026 | Jallal BahijaCHIEF EXECUTIVE OFFICER | Option exercise | 23,817 | — | Form 4 |
| Feb 17, 2026 | Berman David MHEAD OF R&D | Option exercise | 11,824 | — | Form 4 |
| Feb 17, 2026 | St Leger Tina AmberCHIEF HR OFFICER | Option exercise | 2,119 | — | Form 4 |
| Feb 17, 2026 | GOLL JOHNSVP, FINANCE & CAO | Option exercise | 1,351 | — | Form 4 |
| Dec 5, 2025 | Berman David MHEAD OF R&D | Sale | 572 | $22.96K | Form 4 |
| Dec 5, 2025 | Berman David MHEAD OF R&D | Option exercise | 572 | $9.99K | Form 4 |
| Dec 4, 2025 | Berman David MHEAD OF R&D | Sale | 31,341 | $1.26M | Form 4 |
| Dec 4, 2025 | Berman David MHEAD OF R&D | Option exercise | 31,341 | $547.21K | Form 4 |
| Nov 28, 2025 | Berman David MHEAD OF R&D | Sale | 5,521 | $221.34K | Form 4 |
| Nov 28, 2025 | Berman David MHEAD OF R&D | Option exercise | 5,521 | $96.40K | Form 4 |
| Nov 26, 2025 | Berman David MHEAD OF R&D | Sale | 69,404 | $2.78M | Form 4 |
| Nov 26, 2025 | Berman David MHEAD OF R&D | Option exercise | 69,404 | $1.21M | Form 4 |
| Nov 25, 2025 | Berman David MHEAD OF R&D | Sale | 18,020 | $721.34K | Form 4 |
| Nov 25, 2025 | Berman David MHEAD OF R&D | Option exercise | 18,020 | $314.63K | Form 4 |
| Nov 24, 2025 | Berman David MHEAD OF R&D | Sale | 100 | $4.00K | Form 4 |
| Nov 24, 2025 | Berman David MHEAD OF R&D | Option exercise | 100 | $1.75K | Form 4 |
| Sep 30, 2025 | Berman David MHEAD OF R&D | Sale | 61,849 | $2.18M | Form 4 |
| Sep 30, 2025 | Berman David MHEAD OF R&D | Option exercise | 61,849 | $1.08M | Form 4 |
| Sep 15, 2025 | Berman David MHEAD OF R&D | Sale | 200 | $7.00K | Form 4 |
| Sep 15, 2025 | Berman David MHEAD OF R&D | Option exercise | 200 | $3.49K | Form 4 |
| Sep 12, 2025 | Berman David MHEAD OF R&D | Sale | 1,300 | $47.20K | Form 4 |
| Sep 12, 2025 | Berman David MHEAD OF R&D | Sale | 21,232 | $756.50K | Form 4 |
| Sep 12, 2025 | Berman David MHEAD OF R&D | Option exercise | 22,532 | $393.41K | Form 4 |
| Sep 11, 2025 | Berman David MHEAD OF R&D | Sale | 19,081 | $692.26K | Form 4 |
| Sep 11, 2025 | Berman David MHEAD OF R&D | Option exercise | 19,081 | $333.15K | Form 4 |
| Sep 10, 2025 | Berman David MHEAD OF R&D | Sale | 1,200 | $44.12K | Form 4 |
| Sep 10, 2025 | Berman David MHEAD OF R&D | Sale | 30,138 | $1.09M | Form 4 |
| Sep 10, 2025 | Berman David MHEAD OF R&D | Option exercise | 31,338 | $547.16K | Form 4 |
| Mar 17, 2025 | BAKER BROS. ADVISORS LP & 667, L.P. & Baker Bros. Advisors (GP) LLC & Baker Brothers Life Sciences LP & BAKER FELIX & BAKER JULIANDirector | Buy | 92,349 | $2.73M | Form 4 |
| Mar 17, 2025 | BAKER BROS. ADVISORS LP & 667, L.P. & Baker Bros. Advisors (GP) LLC & Baker Brothers Life Sciences LP & BAKER FELIX & BAKER JULIANDirector | Buy | 8,589 | $253.89K | Form 4 |
| Mar 17, 2025 | BAKER BROS. ADVISORS LP & 667, L.P. & Baker Bros. Advisors (GP) LLC & Baker Brothers Life Sciences LP & BAKER FELIX & BAKER JULIANDirector | Buy | 646,290 | $19.22M | Form 4 |
| Mar 17, 2025 | BAKER BROS. ADVISORS LP & 667, L.P. & Baker Bros. Advisors (GP) LLC & Baker Brothers Life Sciences LP & BAKER FELIX & BAKER JULIANDirector | Buy | 60,110 | $1.79M | Form 4 |
| Apr 1, 2024 | St Leger Tina AmberCHIEF HR OFFICER | Sale | 4,375 | $280.26K | Form 4 |
| Apr 1, 2024 | St Leger Tina AmberCHIEF HR OFFICER | Option exercise | 4,375 | $130.68K | Form 4 |
| Feb 28, 2024 | Berman David MHEAD OF R&D | Sale | 1,200 | $84.54K | Form 4 |
| Feb 28, 2024 | Berman David MHEAD OF R&D | Sale | 10,937 | $762.64K | Form 4 |
| Feb 28, 2024 | Berman David MHEAD OF R&D | Sale | 7,472 | $514.37K | Form 4 |
| Feb 28, 2024 | Berman David MHEAD OF R&D | Sale | 16,900 | $1.14M | Form 4 |
| Feb 28, 2024 | Berman David MHEAD OF R&D | Option exercise | 36,509 | $637.45K | Form 4 |
| Feb 27, 2024 | Berman David MHEAD OF R&D | Sale | 3,394 | $244.27K | Form 4 |
| Feb 27, 2024 | Berman David MHEAD OF R&D | Sale | 25,944 | $1.85M | Form 4 |
| Feb 27, 2024 | Berman David MHEAD OF R&D | Sale | 21,152 | $1.49M | Form 4 |
| Feb 27, 2024 | Berman David MHEAD OF R&D | Sale | 4,448 | $308.91K | Form 4 |
| Feb 27, 2024 | Berman David MHEAD OF R&D | Option exercise | 54,938 | $959.22K | Form 4 |
| Feb 26, 2024 | Berman David MHEAD OF R&D | Sale | 2,037 | $145.26K | Form 4 |
| Feb 26, 2024 | Berman David MHEAD OF R&D | Sale | 26,516 | $1.87M | Form 4 |
| Feb 26, 2024 | Berman David MHEAD OF R&D | Option exercise | 28,553 | $498.54K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4